187 participants
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-16
- Start Date:
- 2024-02-22
- Completion:
- 2028-08-01
Conditions
- Multiple Myeloma
Interventions
- DRUG
No Results Yet